ArticleBioengineered2022

Ramelteon protects against human pulmonary microvascular endothelial cell injury induced by lipopolysaccharide (LPS) via activating nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway.

Wenjun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.